Canada markets closed

Kyverna Therapeutics, Inc. (KYTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.50+0.14 (+1.90%)
At close: 04:00PM EDT
7.50 0.00 (0.00%)
After hours: 07:33PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 317.33M
Enterprise Value -41.62M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.88
Enterprise Value/Revenue 3.34k
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-75.55%
S&P500 52-Week Change 323.20%
52 Week High 330.60
52 Week Low 36.75
50-Day Moving Average 313.57
200-Day Moving Average 319.81

Share Statistics

Avg Vol (3 month) 3571.35k
Avg Vol (10 day) 31.35M
Shares Outstanding 543.12M
Implied Shares Outstanding 643.12M
Float 822.54M
% Held by Insiders 110.77%
% Held by Institutions 181.93%
Shares Short (Jun 14, 2024) 43.23M
Short Ratio (Jun 14, 2024) 45.14
Short % of Float (Jun 14, 2024) 413.56%
Short % of Shares Outstanding (Jun 14, 2024) 47.49%
Shares Short (prior month May 15, 2024) 42.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -78.31M
Net Income Avi to Common (ttm)-75.92M
Diluted EPS (ttm)-1.76
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)369.79M
Total Cash Per Share (mrq)8.58
Total Debt (mrq)10.85M
Total Debt/Equity (mrq)3.01%
Current Ratio (mrq)17.17
Book Value Per Share (mrq)8.37

Cash Flow Statement

Operating Cash Flow (ttm)-66.48M
Levered Free Cash Flow (ttm)N/A